Poultry vaccines help prevent harmful pathogenic bacteria and viruses from infecting poultry populations. Poultry vaccines help protect chickens, ducks, turkeys, and other domesticated birds from various poultry diseases such as Newcastle disease, avian influenza, infectious bronchitis, and Marek's disease. Poultry diseases can have devastating economic impacts on poultry farms through increased mortality rates and reduced productivity.

The global poultry vaccine market is estimated to be valued at US$ 5.25 billion in 2023 and is expected to exhibit a CAGR of 13%  over the forecast period 2023-2031, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:
The rising prevalence of poultry diseases represents a major market opportunity for poultry vaccine manufacturers. Factors such as overcrowding of poultry farms, lack of implementation of biosecurity measures, and international trade of poultry and poultry products have contributed to the spread of various poultry diseases globally in recent years. Additionally, newer strains of pathogens are continuously emerging which existing poultry vaccines may not provide protection against. This growing threat of poultry diseases underscores the need for development of effective vaccines with expanded serotypes or strains to shield poultry populations. The development of novel vaccines tailored against emerging poultry diseases holds significant potential for poultry vaccine manufacturers.

Porter's Analysis
Threat of new entrants: The threat of new entrants is moderate due to the requirements for substantial R&D investments and regulatory approvals.

Bargaining power of buyers: The bargaining power of buyers is high due to the presence of several manufacturers and product differentiation in the market.

Bargaining power of suppliers: The bargaining power of suppliers is moderate due to the availability of substitute raw materials.

Threat of new substitutes: The threat of new substitutes is low as there are no cost-effective alternatives.

Competitive rivalry: The competitive rivalry is high due to the presence of global players.

SWOT Analysis
Strengths: Wide disease coverage and growing demand for improved animal health. Government support for vaccine production.

Weaknesses: High R&D and marketing costs. Stringent regulatory norms.

Opportunities: Untapped regional markets offer significant growth potential. Rise in contract manufacturing.

Threats: Outbreaks of avian influenza pose financial risks. Supply chain disruptions amid pandemic.

Key Takeaways
The global Poultry Vaccine Market Growth  is expected to witness high growth over the forecast period.

The Asia Pacific region dominates the market and is expected to grow at the fastest pace owing to high prevalence of poultry diseases and developing animal healthcare infrastructure. Rapid economic development and rising disposable income in countries like China and India are driving demand.

Key players operating in the poultry vaccine market are Merck & Co., Inc., Zoetis, Inc., Boehringer Ingelheim International GmbH, Ceva, Elanco, and Phibro Animal Health Corporation. These players are focused on expanding their product portfolios and geographic presence through acquisitions and collaborations.

Explore more related article on this topic: https://www.newsstatix.com/poultry-vaccine-market-is-expected-to-be-flourished-by-the-growing-demand-for-poultry-meat-and-egg-consumption/

Explore more related articles: https://masstamilan.tv/parp-inhibitors-a-promising-class-of-drugs-in-cancer-treatment/